Molecular epidemiology of carbapenemase-producing multidrug-resistant gram-negative bacilli isolated from different infection sites
DOI:
https://doi.org/10.33448/rsd-v10i9.18070Keywords:
Gram-negative bacteria; Carbapenemase; Resistant multidrug; Molecular epidemiology.Abstract
Resistance to carbapenemases in gram-negative bacilli (BGN) has become a worldwide problem, increasing the rate of morbidity and mortality. The automated method was used for identification and susceptibility of isolates. And the molecular method was applied in the detection of gram-negative bacilli (BGN) producing carbapenemase. A total of 205 BGN were recovered from different carbapenemase-resistant clinical specimens. Resistance genes blaKPC (57,5%), blaVIM (30,2%), blaGES (17%), blaNDM (15%) and blaSPM (2,4%) were recovered from clinical isolates. The blaIMP gene was not detected in any of the isolates. It is worrying that Pseudomonas aeruginosa and Acinetobacter baumannii represent the majority of isolates (61.6%) recovered from infections at different sites, with high resistance to carbapenems, carrying simultaneously the blaKPC, blaGES and blaVIM genes, as well as found in Enterobactericeae. The most prevalent carbapenemase was blaKPC and blaVIM, followed by blaNDM among the resistant multidrug isolates. These results are a threat to public health, configuring high rates of resistance, limiting therapeutic options.
References
Agyepong, N., et al. (2018). Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana. Antimicrob Resist Infect Control. 9;7:37.
Araújo B. F., et al. (2018). Hypervirulence and biofilm production in KPC-2-producing Klebsiella pneumoniae CG258 isolated in Brazil. J Med Microbiol. 67(4):523-528.
Baek, J. Y., et al. (2019). Plasmid analysis of Escherichia coli isolates from South Korea co-producing NDM-5 and OXA-181 carbapenemases. Plasmid. 104:102417.
Barbarini, D., et al. (2015). Evaluation of carbapenem-resistant Enterobacteriaceae in an Italian setting: report from the trench. Infect Genet Evol. 30:8-14.
Ben Helal, R., et al. (2018). Occurrence and Characterization of Carbapenemase-Producing Enterobacteriaceae in a Tunisian Hospital. Microb Drug Resist. 24(9):1361-1367.
Benmahmod, A. B, et al. (2019). Prevalence and Mechanisms of Carbapenem Resistance Among Acinetobacter baumannii Clinical Isolates in Egypt. Microb Drug Resist. 25(4):480-488.
Brink, A. J. (2019). Epidemiology of carbapenem-resistant Gram-negative infections globally. Curr Opin Infect Dis. 32(6):609-616.
Carvalho-Assef, A. P, et al. (2013). Isolation of Providencia rettgeri producing NDM in Brazil. J Antimicrob Chemother. 68: 2956 - 2957.
Castanheira, M, et al.. (2020). Meropenem-Vaborbactam Activity against Carbapenem-Resistant Enterobacterales Isolates Collected in U.S. Hospitals during 2016 to 2018. Antimicrob Agents Chemother. 64(2). pii: e01951-19.
Cuaical-Ramos, N. M, et al. (2019). Genetic variability of carbapenemase KPC-producing Klebsiella pneumoniae isolated at different states in Venezuela. Variabilidad genética de Klebsiella pneumoniae con carbapenemasa tipo KPC proveniente de diferentes estados de Venezuela. Enferm Infecc Microbiol Clin. 37(2):76-81.
Dirar, M, et al.. (2020). Resistance Patterns and Phenotypic Detection of β-lactamase Enzymes among Enterobacteriaceae Isolates from Referral Hospitals in Khartoum State, Sudan. Cureus. 13;12(3):e7260.
Dretler, A.W, et al. (2020). High Rates of New Delhi Metallo-β-Lactamase Carbapenemase Genes in Multi-Drug Resistant Gram-Negative Bacteria in Nicaragua. Am J Trop Med Hyg. 102(2):384-387.
Escandón-Vargas, K, et al. (2017). The epidemiology of carbapenemases in Latin America and the Caribbean. Expert Rev Anti Infect Ther. 15(3):277-297.
Ferreira, A M, et al. (2016). First report of a clinical isolate of Klebsiella pneumoniae producing metallo-β-lactamase in New Delhi in Brazil. J Hosp Infect. 94: 73-74.
Firmo, E. F, et al. (2019). Association of blaNDM-1 with blaKPC-2 and aminoglycoside-modifying enzymes genes among Klebsiellapneumoniae, Proteus mirabilis and Serratiamarcescens clinical isolates in Brazil. J GlobAntimicrobResist. 21:255-61
Firmo, E. F, et al. (2020). Association of blaNDM-1 with blaKPC-2 and aminoglycoside-modifying enzyme genes among Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens clinical isolates in Brazil. J Glob Antimicrob Resist. 21:255-261
Flores, C, et al. (2020). Genetic Relatedness of NDM-Producing Klebsiella pneumoniae Co-Occurring VIM, KPC, and OXA-48 Enzymes from Surveillance Cultures from an Intensive Care Unit. Microb Drug Resist. 26(10):1219-1226
Girija, S A, et al. (2018). Prevalence of VIM- and GIM-producing Acinetobacter baumannii from patients with severe urinary tract infection. Acta Microbiol Immunol Hung. 65(4):539-550
Hagemann, J. B, et al. (2018). KPC-2 carbapenemase-producing Pseudomonas aeruginosa reaching Germany. J Antimicrob Chemother. 1;73(7):1812-1814
Hassuna, N. A, et al. (2020). Molecular Epidemiology and Mechanisms of High-Level Resistance to Meropenem and Imipenem in Pseudomonas aeruginosa. Infect Drug Resist. 13:285-293
Iovleva, A., & Doi, Y. (2017). Carbapenem-Resistant Enterobacteriaceae. Clin Lab Med. 37(2):303-315
Kiaei, S, et al.. (2019). Emergence of co-existence of blaNDM with rmtC and qnrB genes in clinical carbapenem-resistant Klebsiella pneumoniae isolates in burning center from southeast of Iran. Folia Microbiol (Praha). 64(1):55-62
Labarca, J. A., et al. (2016). Carbapenem resistance in Pseudomonas aeruginosa and Acinetobacter baumannii in the nosocomial setting in Latin America. Crit Rev Microbiol. 42(2):276-92
Logan, L. K., & Weinstein, R. A. (2017). The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. J Infect Dis. 15;215(suppl_1):S28-S36
Lopes, E, et al. (2020). Epidemiology of carbapenemase-producing Klebsiella pneumoniae in northern Portugal: Predominance of KPC-2 and OXA-48. J Glob Antimicrob Resist. (20):30101-6
Mendes, R. E., et al. (2007). Rapid detection and identification of metallo-beta-lactamase-encoding genes by multiplex real-time PCR assay and melt curve analysis. J ClinMicrobiol. 45(2):544-7. 10.1128/JCM.01728-06.
Merradi, M, et al. (2019). Occurrence of VIM-4 metallo-β-lactamase-producing Pseudomonas aeruginosa in an Algerian hospital. J Infect Dev Ctries. 13(4):284-290.
Mohapatra, D. P, et al.. (2018). Extensively drug-resistant and pandrug-resistant Gram-negative bacteria in a tertiary-care hospital in Eastern India: A 4-year retrospective study. J Glob Antimicrob Resist. 15:246-249
Nordmann, P., et al. (2011). Global spread of carbapenemase producing Enterobacteriaceae. Emerg Infect Dis 17:1791–1798
Nordmann, P., & Poirel, L. (2019). Epidemiology and Diagnostics of Carbapenem Resistance in Gram-negative Bacteria. Clin Infect Dis. 13;69(Suppl 7):S521-S528
Oteo, J, et al. (2013). Spanish Collaborating Group for the Antibiotic Resistance Surveillance Program. Carbapenemase-producing enterobacteriaceae in Spain in 2012. Antimicrob Agents Chemother. 57(12):6344-7.
Pacheco, T., et al. (2019). Pseudomonas aeruginosa Coharboring BlaKPC-2 and BlaVIM-2 Carbapenemase Genes. Antibiotics (Basel) 20;8(3). pii: E98.
Papadimitriou-Olivgeris. M, et al. (2019). Reversal of carbapenemase-producing Klebsiella pneumoniae epidemiology from blaKPC- to blaVIM-harbouring isolates in a Greek ICU after introduction of ceftazidime/avibactam. J Antimicrob Chemother. 1;74(7):2051-2054
Peirano, G, et al. (2018). Genomic epidemiology of global Carbapenemase - producer of Enterobacter spp., 2008-2014. Emerg Infect Dis. (6):1010-1019
Petrova, A. P, et al. (2017). Carbapenemase Production of Clinical Isolates Acinetobacter baumannii and Pseudomonas aeruginosa from a Bulgarian University Hospital. Folia Med (Plovdiv). 20;59(4):413-422.
Poirel, L., et al. (2012). Genetic Features of the Widespread Plasmid Coding for the Carbapenemase OXA-48. Antimicrob Agents Chemother. 56 (1): 559-562. 10.1128 / AAC.05289-11
Sah, R, et al. (2019). Detection of Pan drug resistance OXA-48 producing Providencia in an ICU patient for the first time in Nepal. AntimicrobResistInfectControl. 8:155.
Senchyna, F, et al. (2019). Diversity of resistance mechanisms in carbapenem-resistant Enterobacteriaceae at a health care system in Northern California, from 2013 to 2016. Diagn Microbiol Infect Dis. 93(3):250-257
Simner, P. J, et al. (2017). Carbapenemase Detection among Carbapenem-Resistant Glucose-Nonfermenting Gram-Negative Bacilli. J Clin Microbiol. 55(9):2858-2864.
Soares, C. R. P., et al. (2020). First report of a blaNDM-resistant gene in a Klebsiella aerogenes clinical isolate from Brazil. Journal of the Brazilian Society of Tropical Medicine. 21;54:e02622020.
Soliman, A. M, et al. (2020). Genetic analysis of carbapenemase-producing Gram-negative bacteria isolated from a university teaching hospital in Egypt. Infect Genet Evol. 77:104065.
Telling, K., et al. (2018). Multidrug resistant Pseudomonas aeruginosa in Estonian hospitals. BMC Infect Dis. 11;18(1):513
Tian D, et al. (2020). Dissemination of the bla NDM-5 Gene via IncX3-Type Plasmid among Enterobacteriaceae in Children. mSphere. 5(1). pii: e00699-19
Uc-Cachón, A. H., et al.. (2019). High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico. Medicina (Kaunas). 13;55(9):588
Wang, C, et al. (2006). An isolate of Pseudomonas aeruginosa that produces the extended spectrum beta-lactamase GES-5. J Antimicrob Chemother. 57 (6): 1261-2. 10.1093 / jac / dkl116
Wang, Q, et al. (2018). Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016). Clin Infect Dis. 13;67(suppl_2):S196-S205
Wilson, H., & Török, M. E. (2018). Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae. Microb Genom. 4(7):e000197.
Yaghi, J, et al. (2020). Unusually High Prevalence of Cosecretion of Ambler Class A and B Carbapenemases and Nonenzymatic Mechanisms in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa in Lebanon. Microb Drug Resist. 26(2):150-159
Yan, J, et al. (2017). Multidrug Resistance Mechanisms of Carbapenem Resistant Klebsiella pneumoniae Strains Isolated in Chongqing, China. Ann Lab Med. 37(5):398-407
Zeynudin, A., et al.. (2018). Prevalence and antibiotic susceptibility pattern of CTX-M type extended-spectrum β-lactamases among clinical isolates of gram-negative bacilli in Jimma, Ethiopia. BMC Infect Dis. 20;18(1):524
Zhang, Y., et al. (2018). Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network. Antimicrob Agents Chemother. 25;62(2):e01882-17
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Cynthia Regina Pedrosa Soares; Felipe Rogerio Ferreira da Silva ; Jorge Belém Oliveira Júnior; Paulo Sérgio Ramos de Araújo; Elza Ferreira Firmo
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
